消化酶缓释漂浮微球的制备与表征

IF 0.3 Q4 PHARMACOLOGY & PHARMACY Current Drug Therapy Pub Date : 2024-01-30 DOI:10.2174/0115748855274979231228103038
Bhupendra G. Prajapati, Anand Bhagat, Biswajit Basu
{"title":"消化酶缓释漂浮微球的制备与表征","authors":"Bhupendra G. Prajapati, Anand Bhagat, Biswajit Basu","doi":"10.2174/0115748855274979231228103038","DOIUrl":null,"url":null,"abstract":"\n\nPepsin is a proteolytic enzyme which is widely used as a digestive aid. Its\ndose is 300 mg - 1 gm per day in divided doses. Its biological half-life is around 3.5 hrs. Pepsin is\nactive only in the acidic pH of the stomach; its activity decreases tremendously in the basic pH. So,\nit is required to retain in the stomach for maximum proteolytic activity. The goal of the current effort\nis to develop and assess an oral controlled floating drug delivery system for pepsin that will shorten\nits stay in the stomach and result in a longer effect.\n\n\n\nThe 12-hour sustained effect of pepsin floating microspheres was planned. This also improves the stability of the Pepsin by immobilizing them on the microsphere. Pepsin is widely used in\nchronic gastritis, so developing a floating drug delivery system is therefore necessary. In light of the\naforementioned principles, a critical need for the creation of a dosage form to administer Pepsin in\nthe stomach and boost the enzyme's effectiveness, enabling sustained action, was identified. The current study used a methodical strategy to create floating microspheres of Pepsin dosage forms.\n\n\n\nOptimization was done for floating ability, yield, entrapment efficiency, and release study\nusing different concentrations of ethylcellulose & HPMC E4M. For parameter optimization and to\ndemonstrate the significant impact of variables, 32 full factorial designs were used. The manufactured\nmicrospheres had good encapsulation rates, excellent floating, & excellent micromeritic properties as\nsingle-unit dosage forms.\n\n\n\nIt has been demonstrated that pepsin prepared as floating microspheres can be used to\nimprove proteolytic activity and extend pepsin's gastric residence.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preparation & Characterization of Sustained-release Floating Microsphere\\nof Digestive Enzymes\",\"authors\":\"Bhupendra G. Prajapati, Anand Bhagat, Biswajit Basu\",\"doi\":\"10.2174/0115748855274979231228103038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nPepsin is a proteolytic enzyme which is widely used as a digestive aid. Its\\ndose is 300 mg - 1 gm per day in divided doses. Its biological half-life is around 3.5 hrs. Pepsin is\\nactive only in the acidic pH of the stomach; its activity decreases tremendously in the basic pH. So,\\nit is required to retain in the stomach for maximum proteolytic activity. The goal of the current effort\\nis to develop and assess an oral controlled floating drug delivery system for pepsin that will shorten\\nits stay in the stomach and result in a longer effect.\\n\\n\\n\\nThe 12-hour sustained effect of pepsin floating microspheres was planned. This also improves the stability of the Pepsin by immobilizing them on the microsphere. Pepsin is widely used in\\nchronic gastritis, so developing a floating drug delivery system is therefore necessary. In light of the\\naforementioned principles, a critical need for the creation of a dosage form to administer Pepsin in\\nthe stomach and boost the enzyme's effectiveness, enabling sustained action, was identified. The current study used a methodical strategy to create floating microspheres of Pepsin dosage forms.\\n\\n\\n\\nOptimization was done for floating ability, yield, entrapment efficiency, and release study\\nusing different concentrations of ethylcellulose & HPMC E4M. For parameter optimization and to\\ndemonstrate the significant impact of variables, 32 full factorial designs were used. The manufactured\\nmicrospheres had good encapsulation rates, excellent floating, & excellent micromeritic properties as\\nsingle-unit dosage forms.\\n\\n\\n\\nIt has been demonstrated that pepsin prepared as floating microspheres can be used to\\nimprove proteolytic activity and extend pepsin's gastric residence.\\n\",\"PeriodicalId\":11004,\"journal\":{\"name\":\"Current Drug Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2024-01-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Drug Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115748855274979231228103038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855274979231228103038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

胃蛋白酶是一种蛋白水解酶,被广泛用作助消化剂。其剂量为每天 300 毫克至 1 克,分次服用。其生物半衰期约为 3.5 小时。胃蛋白酶只在胃的酸性 pH 值下才有活性;在碱性 pH 值下,其活性会大大降低。因此,胃蛋白酶需要保留在胃中才能发挥最大的蛋白分解活性。目前努力的目标是开发和评估一种胃蛋白酶口服可控浮动给药系统,以缩短其在胃中的停留时间,延长其药效。此外,通过将胃蛋白酶固定在微球上,还能提高胃蛋白酶的稳定性。胃蛋白酶被广泛用于慢性胃炎,因此开发一种浮动给药系统很有必要。根据上述原理,亟需创造一种剂型,用于胃内给药胃蛋白酶,并提高酶的效力,使其能够持续发挥作用。目前的研究采用了一种方法策略来制造胃蛋白酶漂浮微球剂型,并使用不同浓度的乙基纤维素和 HPMC E4M 对漂浮能力、产量、包埋效率和释放研究进行了优化。为了优化参数和证明变量的显著影响,采用了 32 种全因子设计。结果表明,以漂浮微球形式制备的胃蛋白酶可用于提高蛋白溶解活性和延长胃蛋白酶的胃停留时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Preparation & Characterization of Sustained-release Floating Microsphere of Digestive Enzymes
Pepsin is a proteolytic enzyme which is widely used as a digestive aid. Its dose is 300 mg - 1 gm per day in divided doses. Its biological half-life is around 3.5 hrs. Pepsin is active only in the acidic pH of the stomach; its activity decreases tremendously in the basic pH. So, it is required to retain in the stomach for maximum proteolytic activity. The goal of the current effort is to develop and assess an oral controlled floating drug delivery system for pepsin that will shorten its stay in the stomach and result in a longer effect. The 12-hour sustained effect of pepsin floating microspheres was planned. This also improves the stability of the Pepsin by immobilizing them on the microsphere. Pepsin is widely used in chronic gastritis, so developing a floating drug delivery system is therefore necessary. In light of the aforementioned principles, a critical need for the creation of a dosage form to administer Pepsin in the stomach and boost the enzyme's effectiveness, enabling sustained action, was identified. The current study used a methodical strategy to create floating microspheres of Pepsin dosage forms. Optimization was done for floating ability, yield, entrapment efficiency, and release study using different concentrations of ethylcellulose & HPMC E4M. For parameter optimization and to demonstrate the significant impact of variables, 32 full factorial designs were used. The manufactured microspheres had good encapsulation rates, excellent floating, & excellent micromeritic properties as single-unit dosage forms. It has been demonstrated that pepsin prepared as floating microspheres can be used to improve proteolytic activity and extend pepsin's gastric residence.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
期刊最新文献
Revolutionizing Healthcare and Drug Discovery: The Impact of Artificial Intelligence on Pharmaceutical Development Advancements in Natural Alkaloid-Loaded Drug Delivery Systems for Enhanced Peptic Ulcer Treatment: A Review Internet of Healthcare Things Based Detection of EEG Epileptic Seizures: A Smart System Exploring the Potential of Pectin for Gastro Retentive Drug Delivery Systems: From Orchard to Drug Delivery Gold Nanoparticles: An Emerging Novel Technology for Targeted Delivery System for Site-Specific Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1